12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·03/06/2026 17:05:41
Listen to the news
Gainers
- Day One Biopharmaceutical (NASDAQ:DAWN) stock rose 65.7% to $21.18 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion.
- Edesa Biotech (NASDAQ:EDSA) stock increased by 56.23% to $5.64. The company's market cap stands at $30.1 million.
- Firefly Neuroscience (NASDAQ:AIFF) shares increased by 36.97% to $1.95. The market value of their outstanding shares is at $20.1 million.
- AN2 Therapeutics (NASDAQ:ANTX) stock increased by 33.91% to $2.29. The company's market cap stands at $46.8 million.
- Pulmonx (NASDAQ:LUNG) stock increased by 32.29% to $2.13. The company's market cap stands at $66.4 million. As per the news, the Q4 earnings report came out 2 days ago.
- Q/C Technologies (NASDAQ:QCLS) stock increased by 31.6% to $4.58. The market value of their outstanding shares is at $27.3 million.
Losers
- Calidi Biotherapeutics (AMEX:CLDI) stock decreased by 50.7% to $0.38 during Friday's regular session. The market value of their outstanding shares is at $5.5 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock declined by 40.31% to $0.1.
- Owlet (NYSE:OWLT) stock fell 36.01% to $7.52. The company's market cap stands at $324.0 million. The company's, Q4 earnings came out yesterday.
- Medicus Pharma (NASDAQ:MDCX) stock fell 35.5% to $0.44. The market value of their outstanding shares is at $16.7 million.
- Lunai Bioworks (NASDAQ:LNAI) shares declined by 28.91% to $0.26. The company's market cap stands at $8.7 million.
- OptimizeRx (NASDAQ:OPRX) shares fell 17.93% to $6.18. The company's market cap stands at $139.2 million. The company's, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.